In the post-pandemic era, procurement departments in hospitals, food processing giants, and environmental agencies are shifting from "Just-in-Time" to "Just-in-Case" supply chain models. The demand for Microbial Detection Systems has evolved from simple presence/absence testing to high-throughput, quantitative analysis capable of identifying multiple pathogens in a single run (multiplexing).
The global market for molecular diagnostics is projected to grow significantly as automation reduces the "human error" factor. Modern factories are integrating PCR technologies directly into production lines (At-line testing) for real-time monitoring of microbial loads in pharmaceutical and food manufacturing environments.
The industry is transitioning from standard PCR to Real-Time qPCR and Digital PCR (dPCR). These systems provide absolute quantification without the need for standard curves, offering unprecedented sensitivity for detecting trace contaminants in complex matrices like soil, wastewater, and blood products.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
sq.m Facility
Experts
Countries Served
Certified Quality
Providing rapid diagnostic tools for infectious diseases, oncology biomarkers, and genetic disorders. Our systems enable hospitals to reduce turnaround time (TAT) from days to hours, facilitating immediate clinical decisions.
Automated detection of pathogens like Salmonella, Listeria, and E. coli. Integrating PCR systems with robotic sampling platforms ensures that large-scale production meets stringent international safety standards (HACCP).
Specialized solutions for wastewater surveillance and air quality pathogen monitoring. These systems act as early-warning arrays for public health departments to detect community-level outbreaks before they reach clinics.
QC solutions for sterility testing and mycoplasma detection in cell therapy and vaccine production. Compliance with 21 CFR Part 11 ensures data integrity and audit readiness.
Our technical roadmap focuses on three core pillars: Portability, Connectivity, and Autonomy. We are currently developing "Miniaturized PCR Lab" solutions that bring the power of a central laboratory to remote field locations. By leveraging AI-driven curve analysis, we eliminate subjective interpretation of results, providing a 'binary' yes/no answer for complex biological samples.
BioX Medical serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. Understanding that regulatory landscapes vary (CE-IVDR, FDA, NMPA), we provide comprehensive documentation and validation support. Our localized service centers offer calibration, maintenance, and training to ensure that your Microbial Detection Systems Factory operations never face downtime.
Real-Time PCR offers significantly faster results (minutes/hours vs. days), higher sensitivity (able to detect low copy numbers of DNA/RNA), and the ability to detect non-culturable organisms. It also allows for quantification, which is critical for monitoring viral loads or bacterial contamination levels.
We implement a multidisciplinary quality management system. This includes comprehensive control procedures during design, manufacturing, and final inspection. Our facility is ISO certified, and products are tested for thermal stability, optical precision, and software reliability to meet international IVD standards.
Yes, through our OEM and ODM services, we provide flexible solutions for diagnostic companies to develop custom assays. Our hardware is "open-system" compatible, meaning it can be programmed to run various third-party reagents and specialized thermal cycling protocols.
We offer remote technical support, video training sessions, and detailed service manuals. For large-scale installations, we can coordinate with local distributors for on-site calibration and preventative maintenance contracts.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
